67 related articles for article (PubMed ID: 20422893)
21. Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses.
Khalid A; Nodit L; Zahid M; Bauer K; Brody D; Finkelstein SD; McGrath KM
Am J Gastroenterol; 2006 Nov; 101(11):2493-500. PubMed ID: 17029619
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic ultrasound-guided fine-needle aspiration in 179 cases: the M. D. Anderson Cancer Center experience.
Shin HJ; Lahoti S; Sneige N
Cancer; 2002 Jun; 96(3):174-80. PubMed ID: 12115306
[TBL] [Abstract][Full Text] [Related]
23. Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer.
Chang KJ; Soetikno RM; Bastas D; Tu C; Nguyen PT
Endoscopy; 2003 Nov; 35(11):962-6. PubMed ID: 14606021
[TBL] [Abstract][Full Text] [Related]
24. A large single-center experience of EUS-guided FNA of the left and right adrenal glands: diagnostic utility and impact on patient management.
Eloubeidi MA; Black KR; Tamhane A; Eltoum IA; Bryant A; Cerfolio RJ
Gastrointest Endosc; 2010 Apr; 71(4):745-53. PubMed ID: 20156622
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of diagnostic value of cytologic sampling by endoscopic ultrasonography-guided fine-needle aspiration and that by endoscopic retrograde pancreatography for the management of pancreatic mass without biliary stricture.
Wakatsuki T; Irisawa A; Bhutani MS; Hikichi T; Shibukawa G; Takagi T; Yamamoto G; Takahashi Y; Yamada Y; Watanabe K; Obara K; Suzuki T; Sato Y
J Gastroenterol Hepatol; 2005 Nov; 20(11):1707-11. PubMed ID: 16246190
[TBL] [Abstract][Full Text] [Related]
26. Quantitative RT-PCR analysis of MMR genes on EUS-guided FNA samples from focal pancreatic lesions.
Gheonea DI; Ciurea ME; Săftoiu A; Ioana M
Hepatogastroenterology; 2012 May; 59(115):916-20. PubMed ID: 22020914
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic endocrine tumor EUS-guided FNA DNA microsatellite loss and mortality.
Fasanella KE; McGrath KM; Sanders M; Brody D; Domsic R; Khalid A
Gastrointest Endosc; 2009 May; 69(6):1074-80. PubMed ID: 19152901
[TBL] [Abstract][Full Text] [Related]
28. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA.
DeWitt J; Yu M; Al-Haddad MA; Sherman S; McHenry L; Leblanc JK
Gastrointest Endosc; 2010 Feb; 71(2):260-5. PubMed ID: 19922924
[TBL] [Abstract][Full Text] [Related]
29. Tumor vessel depiction with contrast-enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer.
Yamashita Y; Ueda K; Itonaga M; Yoshida T; Maeda H; Maekita T; Iguchi M; Tamai H; Ichinose M; Kato J
Pancreas; 2013 Aug; 42(6):990-5. PubMed ID: 23851433
[TBL] [Abstract][Full Text] [Related]
30. ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration.
Wakatsuki T; Irisawa A; Terashima M; Shibukawa G; Takagi T; Imamura H; Takahashi Y; Sato A; Sato M; Ikeda T; Suzuki R; Hikichi T; Obara K; Ohira H
Int J Clin Oncol; 2011 Aug; 16(4):387-94. PubMed ID: 21331767
[TBL] [Abstract][Full Text] [Related]
31. Small cell carcinoma of the pancreas: role of EUS-FNA and subsequent effective chemotherapy using carboplatin and etoposide.
Sakamoto H; Kitano M; Komaki T; Noda K; Chikugo T; Kudo M
J Gastroenterol; 2009; 44(5):432-8. PubMed ID: 19333541
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.
Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
Cancer; 2001 Feb; 91(3):490-5. PubMed ID: 11169931
[TBL] [Abstract][Full Text] [Related]
33. Defining the diagnostic algorithm in pancreatic cancer.
Horwhat JD; Gress FG
JOP; 2004 Jul; 5(4):289-303. PubMed ID: 15254364
[TBL] [Abstract][Full Text] [Related]
34. A new endoscopic ultrasonography image processing method to evaluate the prognosis for pancreatic cancer treated with interstitial brachytherapy.
Xu W; Liu Y; Lu Z; Jin ZD; Hu YH; Yu JG; Li ZS
World J Gastroenterol; 2013 Oct; 19(38):6479-84. PubMed ID: 24151368
[TBL] [Abstract][Full Text] [Related]
35. Effects of EUS-guided intratumoral injection of oligonucleotide STNM01 on tumor growth, histology, and overall survival in patients with unresectable pancreatic cancer.
Nishimura M; Matsukawa M; Fujii Y; Matsuda Y; Arai T; Ochiai Y; Itoi T; Yahagi N
Gastrointest Endosc; 2018 Apr; 87(4):1126-1131. PubMed ID: 29122598
[TBL] [Abstract][Full Text] [Related]
36. [A case of AFP producing pancreatic acinar cell carcinoma diagnosed by EUS FNA and treated by intraarterial injection chemotherapy].
Mori S; Kondoh S; Ryozawa S; Urayama N; Satake M; Kitoh H; Yamashita H; Nakashima T; Gondo T; Okita K
Nihon Shokakibyo Gakkai Zasshi; 2004 Feb; 101(2):177-82. PubMed ID: 15011443
[No Abstract] [Full Text] [Related]
37. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China.
Long J; Luo GP; Xiao ZW; Liu ZQ; Guo M; Liu L; Liu C; Xu J; Gao YT; Zheng Y; Wu C; Ni QX; Li M; Yu X
Cancer Lett; 2014 May; 346(2):273-7. PubMed ID: 24462819
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic cancer: updates on translational research and future applications.
Sarris EG; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):145-8. PubMed ID: 23474558
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic cancer: the stealth cancer. Pancreatic cancer is hard to detect and highly resistant to chemotherapy; new research reveals possible resolutions.
Duke Med Health News; 2009 Apr; 15(4):9-10. PubMed ID: 19639663
[No Abstract] [Full Text] [Related]
40. EUS training and credentialing.
Dill JE
Gastrointest Endosc; 2004 Jun; 59(7):934. PubMed ID: 15212009
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
